Sign in

CIK 0000882095

  • Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943047598
Phone
+1 650-574-3000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$36,996,096
in 12 filings, $37.0M under 10b5-1 plans

Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-10 O'Day Daniel Patrick Chairman & CEO Option exercise +7,347 391,032
2023-12-10 O'Day Daniel Patrick Chairman & CEO Shares withheld for taxes −3,341 $79.02 $264K 387,691
2023-12-10 O'Day Daniel Patrick Chairman & CEO Option exercise · Restricted Stock Unit −7,347 110,892
2023-12-10 Dickinson Andrew D Chief Financial Officer Option exercise +2,617 107,728
2023-12-10 Dickinson Andrew D Chief Financial Officer Shares withheld for taxes −1,194 $79.02 $94K 106,534
2023-12-10 Dickinson Andrew D Chief Financial Officer Option exercise · Restricted Stock Unit −2,617 38,834
2023-11-10 Dickinson Andrew D Chief Financial Officer Option exercise +1,912 105,915
2023-11-10 Dickinson Andrew D Chief Financial Officer Shares withheld for taxes −804 $75.92 $61K 105,111
2023-11-10 Dickinson Andrew D Chief Financial Officer Option exercise · Restricted Stock Unit −1,912 41,451
2023-10-25 Telman Deborah H EVP, Corporate Affairs & GC Option exercise +514 7,005
2023-10-25 Telman Deborah H EVP, Corporate Affairs & GC Shares withheld for taxes −243 $78.39 $19K 6,762
2023-10-25 Telman Deborah H EVP, Corporate Affairs & GC Option exercise · Restricted Stock Unit −514 32,337
2023-10-17 Dickinson Andrew D Chief Financial Officer Sale 10b5-1 −5,000 $80.00 $400K 104,003
2023-09-28 Lofton Kevin E Director Grant or award · Phantom Stock +31.46 3,194.72
2023-09-12 Parsey Merdad Chief Medical Officer Sale 10b5-1 −1,501 $76.99 $116K 70,130
2023-09-10 Mercier Johanna Chief Commercial Officer Option exercise +2,730 90,744
2023-09-10 Mercier Johanna Chief Commercial Officer Shares withheld for taxes −1,256 $76.00 $95K 89,488
2023-09-10 Mercier Johanna Chief Commercial Officer Option exercise · Restricted Stock Unit −2,730 42,717
2023-09-10 Dickinson Andrew D Chief Financial Officer Option exercise +2,619 110,206
2023-09-10 Dickinson Andrew D Chief Financial Officer Shares withheld for taxes −1,203 $76.00 $91K 109,003

Page 32 of 43 · 851 trades